Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sovos Brands Prices Stockholders’ Equity Offering At 4.8% Discount

Sovos Brands Inc (NASDAQ:SOVO) has priced an underwritten secondary public offering of 8.5 million shares by certain stockholders at $14.00 per…
byShivani Kumaresan
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Sovos Brands Inc (NASDAQ:SOVO) has priced an underwritten secondary public offering of 8.5 million shares by certain stockholders at $14.00 per share.
  • The offer price represents a 4.8% discount on the company’s closing price on August 10, 2022.
  • The offering consists entirely of secondary shares to be sold by the selling stockholders, who will receive all of the proceeds.
  • The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1.3 million shares at the public offering price.
  • The offering is expected to close on August 15, 2022.
  • Price Action: SOVO shares are trading lower by 1.56% at $14.47 in premarket on the last check Thursday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GSK Announced Phase IIa Study Results for a New First-in-class Candidate Medicine for Patients With Tuberculosis Showed Early Bactericidal Activity With Low, Once-daily Oral Dose After 14 Days of Treatment in Users With Drug-susceptible Pulmonary TB

By Charles Gross
November 14, 7:17 AM
GSK plc (LSE/NYSE: GSK) today announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well tolerated and showed early bactericidal activity with a low, once-daily oral dose after 14 days of treatment in participants with drug-susceptible pulmonary tuberculosis.

GSK